drugset / Trial / NCT00927030

Melatonin for Sleep in Children With Autism

NCT00927030

RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to determine if liquid supplemental melatonin is an effective treatment for children with autism who have sleep problems related to insomnia (difficulty falling asleep).

Timeline

Start
2008-01
Primary completion
2010-04
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 1 mg
Subject Melatonin Small molecule 3 mg
Subject Melatonin Small molecule 6 mg
Subject Melatonin Small molecule 9 mg